Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
7.14
-0.17 (-2.33%)
Feb 4, 2026, 3:08 PM CST

SHE:300639 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
696.76712.36764.931,025521.97390.96
Short-Term Investments
-250.29----
Trading Asset Securities
242.050.63307.05387.06677.14860
Cash & Short-Term Investments
938.81963.271,0721,4121,1991,251
Cash Growth
3.63%-10.14%-24.07%17.74%-4.14%376.86%
Accounts Receivable
861.881,0991,8912,7251,116576.86
Other Receivables
12.1210.9813.5616.3214.539.57
Receivables
8741,1101,9042,7421,131586.43
Inventory
79.4865.6699.56118.74147.1496.3
Prepaid Expenses
-0.015.115.5423.3712.01
Other Current Assets
83.7887.0996.13112.4451.9516.42
Total Current Assets
1,9762,2263,1774,4002,5521,962
Property, Plant & Equipment
1,3261,4081,4371,3171,168598.45
Long-Term Investments
330.21545.71533.12521.98273.8175.98
Other Intangible Assets
251.14259.28249.58185.21100.14100.72
Long-Term Deferred Tax Assets
75.1286.32195.35180.2529.221.07
Long-Term Deferred Charges
61.2460.979.9581.6182.6250.65
Other Long-Term Assets
263.0837.6153.554.8925.5847.97
Total Assets
4,2824,6235,7266,7414,2312,857
Accounts Payable
95.03106.75143.67466.69221.1586.2
Accrued Expenses
64.0972.6585.83399.86174.9698.07
Short-Term Debt
121.632.1298.48151.575.27
Current Portion of Leases
5.397.918.8610.486.79-
Current Income Taxes Payable
14.728.378.1352.7194.8810.83
Current Unearned Revenue
12.5714.868.9322.1613.1624.69
Other Current Liabilities
197.36209.46180.412.4615.157.96
Total Current Liabilities
390.16441.55507.921,363677.59303.02
Long-Term Debt
95.5752.7928.27---
Long-Term Leases
4.35.1917.430.5326.860.17
Long-Term Unearned Revenue
7.519.1511.8214.1316.5618.91
Long-Term Deferred Tax Liabilities
55.7167.0761.6106.1435.360.58
Other Long-Term Liabilities
0.510.690.05---
Total Liabilities
553.76576.44627.051,514756.37322.69
Common Stock
646.5646.5649.15439.52293.89235.38
Additional Paid-In Capital
726.71785.49877.521,1901,2801,361
Retained Earnings
2,4232,5513,2473,2581,634851.33
Treasury Stock
-110.15-65.13-100-149.99-99.99-50.02
Comprehensive Income & Other
154.71191.85187.26169.8486.73-7.63
Total Common Equity
3,8414,1094,8614,9073,1942,391
Minority Interest
-112.19-62.9237.46320.38280.63143.74
Shareholders' Equity
3,7294,0475,0995,2283,4752,534
Total Liabilities & Equity
4,2824,6235,7266,7414,2312,857
Total Debt
106.2687.5156.65139.49185.1575.44
Net Cash (Debt)
832.55875.761,0151,2721,0141,176
Net Cash Growth
2.55%-13.75%-20.20%25.48%-13.74%348.50%
Net Cash Per Share
1.301.361.811.931.541.92
Filing Date Shares Outstanding
627.62635.3294.06651.68655.3659
Total Common Shares Outstanding
627.62635.3294.06651.68655.3659
Working Capital
1,5861,7842,6693,0371,8751,659
Book Value Per Share
6.126.4716.537.534.873.63
Tangible Book Value
3,5903,8504,6124,7223,0942,290
Tangible Book Value Per Share
5.726.0615.687.254.723.47
Buildings
-1,1151,070991.09786.57424.56
Machinery
-701.8683.89600.83521.92281.13
Construction In Progress
-232.59171.3858.6238.2949.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.